Last update 25 Nov 2024
MT-1013
Last update 25 Nov 2024
Overview
Basic Info
Drug Type Synthetic peptide |
Synonyms MT 1013, MT1013 |
Target |
Mechanism PTH1R antagonists(Parathyroid hormone receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
7
Clinical Trials associated with MT-1013A Multicenter, Randomized, Single Blind, Positive Controlled, and Placebo-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of MT1013 Injection in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Undergoing Maintenance Hemodialysis
评价注射用 MT1013 治疗接受维持性血液透析的慢性肾脏病伴发继发性甲状旁腺功能亢进受试者的有效性和安全性的多中心、随机、单盲、阳性对照及安慰剂对照的 II 期临床研究
[Translation] A multicenter, randomized, single-blind, positive-controlled and placebo-controlled Phase II clinical study to evaluate the efficacy and safety of MT1013 for injection in the treatment of chronic kidney disease with secondary hyperparathyroidism in subjects receiving maintenance hemodialysis
评价注射用 MT1013 治疗接受维持性血液透析的慢性肾脏病伴发继发性甲状旁腺功能亢进患者的安全性和有效性的多中心、开放、单臂 Ⅱb 期临床研究
[Translation] A multicenter, open-label, single-arm Phase IIb clinical study to evaluate the safety and efficacy of MT1013 for injection in the treatment of patients with chronic kidney disease and secondary hyperparathyroidism receiving maintenance hemodialysis
100 Clinical Results associated with MT-1013
Login to view more data
100 Translational Medicine associated with MT-1013
Login to view more data
100 Patents (Medical) associated with MT-1013
Login to view more data
100 Deals associated with MT-1013
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chronic Kidney Diseases | Phase 2 | CN | 04 Nov 2024 | |
| Hyperparathyroidism, Secondary | Phase 2 | CN | 07 Apr 2023 | |
| Hypercalcemia | Phase 2 | US | - | |
| Hypercalcemia | Phase 2 | CN | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free